Comparison of double-lumen endobronchial tube and a combination of LMA ProSeal and bronchial blocker for video assisted thoracoscopic surgery

Phase 3

• Conditions: ung tumor

• Registration Number: JPRN-jRCT1042200060
• Lead Sponsor: akanishi Toshiyuki

Brief Summary

The combination of ProSeal laryngeal mask airway and bronchial blocker did not significantly reduce hoarseness compared to the double-lumen endobronchial tube.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-11-13
• Study Completion: 2022-06-30
• Results First Posted: 2023-05-01
• Last Update Posted: 27 May 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

(1) Patients undergoing thoracoscopic lung surgery (including robotic-assisted surgery) for clinical stage I lung cancer under general anesthesia
(2) ASA PS (American Society of Anesthesiologists Physical Status) 1 to 3
(3) Patients for whom written consent has been obtained from the individual

Exclusion Criteria

(1) Patients undergoing emergency surgery
(2) Patients after tracheotomy
(3) Patients who are intubated preoperatively
(4) Patients with a history of intrathoracic surgery on the operative side
(5) Patients with a history of intrathoracic lesions on the operative side and expected adhesions
(6) Patients with anticipated tumor invasion of the bronchial tubes or vessels.
(7) Patients with an anatomical abnormality that makes normal isolated lung ventilation difficult, such as a tracheal bronchus
(8) Patients who undergo a procedure that cannot be managed with normal isolated lung ventilation, such as surgery on the left and right main bronchus.
(9) Patients who are expected to have difficulty in securing their airway
(10) Patiwnts with severe obstructive ventilatory disturbance (1-second rate <50%)
(11) Patients who are allergic to the drug to be used
(12) Patients with obvious hoarseness or sore throat preoperatively
(13) Patients who are expected to have difficulty in postoperative communication due to dementia, sequelae of cerebrovascular disease, etc.
(14) Patients who are judged by the research group to be inappropriate

Study & Design

• Study Type: Interventional
• Study Design: Not specified